Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup,
staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Genotyping may improve risk stratification of high‐risk (HR) human papillomavirus (HPV)‐
positive women in cervical screening programs; however, prospective data comparing the …

Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Pooled data on human papillomavirus (HPV) type distribution in invasive cervical cancer
(ICC) can help to predict the potential impact of HPV type‐specific vaccines and screening …

Mucosal human papillomaviruses (HPV) are the cause of cervical cancer and likely a subset
of head and neck squamous cell carcinomas (HNSCC), yet the global prevalence and type …

This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …

Background and aim Data on type-specific human papillomavirus (HPV) are needed to
investigate HPV-based screening tests and HPV vaccines. However, Chinese relevant data …